Vidian neurectomy has been used to manage intractable vasomotor rhinitis for decades. After the introduction of endoscopic sinus surgery in the 1980s, transnasal endoscopic vidian neurectomy (EVN) was subsequently reported. The most common problem in performing EVN was excessive bleeding from the pterygopalatine fossa. The complexity and vascularity of the pterygopalatine fossa can cause bloody surgical fields and prevent complete neurectomy. In response to this surgical problem, a procedure was developed to use powered instrumentation and coblation during EVN. There were eight cases of EVNs (16 neurectomies) assisted by power instrumentation and coblation from December 2011 to May 2012. The average blood loss of these cases was 37.5 mL (range, 25e50 mL). The average surgical time of each neurectomy was 27.4 minutes (range, 20e35 minutes). No complications occurred in any of the eight cases. Very limited bleeding and less thermal damage were noted while achieving a complete neurectomy.
Introduction
The vidian nerve is composed of the union of postsynaptic parasympathetic fibers and presynaptic sympathetic fibers. The theory behind vidian neurectomy is that inhibits excessive activity of the parasympathetic system by interrupting cholinergic innervation to the nasal mucosa. As endoscopic instrumentation and techniques have advanced, vidian neurectomy can be performed more safely and easily via either a pterygopalatine fossa (PPF) 1 or transsphenoidal approach, 2 resulting in fewer complications. However, since the PPF benefits from extensive hemocirculation, dissection is apt to be obscured by poor surgical fields. Therefore we modified the accepted current technique of EVN and added power instrumentation and coblation to reduce PPF bleeding.
Methods
EVN was provided as a treatment option for patients suffering intractable rhinitis. Possible surgical complications, including permanent dry eyes, were explained to patients prior to surgery. EVN was performed under general anesthesia, with patients lying in reverse Trendelenburg position. Preoperative packing included Cottonoid swabs soaked in a 3-mL solution consisting of 1 mL of 10% cocaine, 1 mL of 1:1000 adrenaline, and 1 mL of saline 10 minutes prior to surgery. A continuous esmolol infusion was used during the surgery to improve surgical fields. 3 The esmolol (100 mg/10 mL) infusion was started 2 minutes prior to initiation of surgery with 0.5 mg/kg for a loading dose and a maintenance infusion of 50 mg/kg/minute. A nominal minimal alveolar concentration of inhaled anesthetic was titrated to achieve a mean arterial blood pressure of 50e75 mmHg. The lateral nasal wall over the region of the posterior fontanelle was infiltrated with 2% xylocaine with 1:80,000 adrenaline. A U-shaped mucosal incision was made with the base centered over the sphenopalatine foramen. A lateral wall periosteal mucosal flap was elevated by suction freer dissector to expose the ethmoid process of the palatine bone. The sphenopalatine artery was identified and cauterized by suction bipolar. The mucosal flap was then elevated toward the sphenoid until the posterior nasal artery was identified and then cauterized. The flap was then advanced posteriorly and inferiorly to the level of choana, to expose the perpendicular plate and sphenoid process of the palatine bone (Fig. 1 ), which were then drilled to allow better exposure of the PPF (Figs. 2 and 3). A coblator was then used to defat the fully exposed PPF, allowing the vidian nerve to be transected without bleeding (Fig. 2) . The navigation system was also utilized to confirm the precise location of vidian nerve or canal (Fig. 4) . The flap was then repositioned and no packing was required.
Results
There were eight cases of EVNs (16 neurectomies) assisted by power instrumentation and coblation from December 2011 to May 2012. Another 24 cases underwent EVNs using traditional electrocauterization from May 2010 to November 2011 as a control group. The average blood loss of these eight cases was 37.5 mL (range, 25e50 mL), and of the control group was 91.7 mL (range, 50e150 mL). The average operation time of each neurectomy was 27.4 minutes (range, 20e35 minutes), and of the control group was 44.4 minutes (range, 30e60 minutes). No complications occurred in any of the eight cases.
Discussion
It is believed that the vidian nerve plays a role in rhinitis, epiphora, crocodile tears, Sluder's neuralgia, cranial and cluster headaches, and corneal ulceration. 4 The vidian nerve exits the lateral part of the anterior end of the carotid canal, passes along the upper part of the anterolateral edge of the foramen lacerum, courses through the vidian canal, and ends in the pterygopalatine ganglion at the posterior part of the PPF.
4e6 It passes forward through the pterygoid canal with its corresponding artery (artery of the pterygoid canal) and is joined by a small ascending sphenoidal branch from the otic ganglion. It then enters the PPF and joins the posterior angle of the pterygopalatine ganglion.
The vidian neurectomy procedure was introduced by Golding-Wood to manage intractable vasomotor rhinitis as well as allergic rhinitis and nasal polyposis in the early 1960s. 7 In the past, various techniques have been described as a means to approach the vidian nerve prior to the development of endoscopic sinus surgery. 7e10 However, these approaches carried the risk of significant postoperative morbidity such as loss of vision, 11 oronasal or oroantral fistula, 9 and catastrophic hemorrhage. Most recently, endoscopic sinus surgery and computed tomography have led to a better understanding of the anatomy of the vidan nerve. 1,12e14 Robinson and Wormald 1 described an endoscopic approach for vidian neurectomy utilizing a series of predefined anatomical landmarks that allow reliable identification of the nerve. Lee et al 2 also reported a novel way to perform vidian neurectomy via an endoscopic intrasphenoidal or transsphenoidal approach. However, this approach is not consistently feasible due to the variable course of the vidian canal through the sphenoid sinus. We performed vidian neurectomy via the PPF approach assisted by power instrumentation, in order to get better exposure of the PPF, after which the true neurectomy could be performed with greater confidence. The posterior pharyngeal nerve is very close to the vidian canal and the vidian neurectomy was often done incorrectly in conjunction with a pharyngeal neurectomy prior to the clear identification of the vidian canal. 15 A blind cauterization of this area will often just result in pharyngeal neurectomy. Coblation then used in the management of bleeding issues from PPF dissection. Within the very tight confines of the PPF, surgical bleeding tends to readily obscure the endoscopic view, but the coblation overcame this problem due to its unique combination of modalities.
Coblation technology is The U.S. Food and Drug Administration (FDA) approved for use in sinus surgery (ArthroCare, Austin, TX, USA). It was first introduced for adenotonsillectomy and turbinate reduction surgery and has been rapidly evolving in indications. In rhinology, the coblator has since been used for sinonasal polyposis 16 and more recently nasopharyngeal angiofibromas. 17 One of the major advantages of the coblator device is the ability of the wand to be used to retract the lesion while simultaneously dissecting, coagulating, irrigating, and suctioning. There is only one other case series that recently reported the use of radiofrequency coblation endoscopic resection of intranasal and sinus tumors in 10 patients. 18 One of the main advantages for its use in the nose is the coblator's unique balance between hemostasis and limited thermal damage. Whereas electrocautery operates at temperatures between 400 C and 600 C, the coblator operates at between 40 C and 70 C. 19 EVNs will be completed in a smooth manner using coblation, without the disadvantages of repeated electrocauterization. Although coblator has its unique advantages, some disadvantages still present. Patients have to pay the extra cost arising from use of the coblator, and the tip of the present model is a little large for neurectomy procedure; however, a smaller neurectomy tip will be available soon.
